Showing results (1571-1580 of 2,166) with videos related to

Sort By:
Pageof 217
Angewandte Chemie (International Ed. in English)|October 11, 2021
Optimized Synthesis of Solution-Processable Crystalline Poly(Triazine Imide) with Minimized Defects for OLED ApplicationDavid Burmeister, Ha Anh Tran, Johannes Müller, et al.
Comprehensive Psychiatry|May 29, 2016
Differential melatonin alterations in cerebrospinal fluid and serum of patients with major depressive disorder and bipolar disorderJ M Bumb, F Enning, J K Mueller, et al.
Video Journal of Sports Medicine|May 1, 2025
Anterior Cruciate Ligament Reconstruction With Bone-Patellar Tendon-Bone Autograft With Concomitant Meniscal Allograft TransplantationJonathan D Groothoff, Richard S Villa, Mark A Glover, et al.
The Journal of Laboratory and Clinical Medicine|November 1, 1992
Mitomycin C-induced colitis in rats: a new animal model of acute colonic inflammation implicating reactive oxygen speciesA Keshavarzian, M I Doria, S Sedghi, et al.
Leukemia|December 22, 2012
Lenalidomide does not increase AML progression risk in RBC transfusion-dependent patients with Low- or Intermediate-1-risk MDS with del(5q): a comparative analysisA Kuendgen, M Lauseker, A F List, et al.
Leukemia|June 24, 2000
Microsatellite instability is not a defining genetic feature of acute myeloid leukemogenesis in adults: results of a retrospective study of 132 patients and review of the literatureL M Rimsza, K J Kopecky, J Ruschulte, et al.
Journal of Internal Medicine|January 22, 2023
Evaluation of SARS-CoV-2 antibody levels on hospital admission as a correlate of protection against mortalitySylvia Mink, Wolfgang List, Guenter Hoefle, et al.
Journal of Intellectual Disability Research : JIDR|February 1, 2003
Identifying bipolar disorders in individuals with intellectual disabilityN N Cain, P W Davidson, A M Burhan, et al.
Wiener Klinische Wochenschrift|August 2, 2005
Lack of impact of ABO blood group or corresponding isoantibodies on the immune response after rabies vaccinationChristoph Buchta, Günther Körmöczi, Georg Heinze, et al.
Leukemia Research|December 26, 2008
A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemiaJeffrey E Lancet, Maria R Baer, George E Duran, et al.
Pageof 217